Enveric Biosciences, Inc.

ENVB - CIK 0000890821

Market cap-

Rank-

SEC filings1,004

ENVB income statement (quarterly)

The table below shows Enveric Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.

Line item	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024
Revenue	-	-	-	-	-	-
Cost of revenue	-	-	-	-	-	-
Gross profit	-	-	-	-	-	-
R&D	$345.97K	$402.42K	$1.26M	$746.37K	$802.72K	$565.00K
SG&A

ENVB annual revenue (10-K history)

Enveric Biosciences, Inc. reported annual revenue of $39.91M for fiscal year 2019. That is down 7.2% from $43.00M in fiscal 2018. Over the 7 fiscal years shown, annual revenue grew from $6.14M (FY 2014) to $39.91M. Figures come from the company's audited annual reports as filed with the SEC.

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.